Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( <scp>RESOLUTION</scp> study)

Although the primary endpoint did not reach statistical significance, luseogliflozin may provide renoprotective benefits in patients with type 2 diabetes mellitus and moderate-to-severe renal impairment, potentially by slowing eGFRcreat decline post-initial decline.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes Investigation
Published
2025-10-09
DOI
https://doi.org/10.1111/jdi.70173
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( RESOLUTION study)

Yosuke Okada, Atsushi Nakagawa, Yutaka Wakasa, Shinji Kume et al.
Journal of Diabetes Investigation
Diabetes Treatment and Management
article

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial ( RESOLUTION study)

Yosuke Okada, Atsushi Nakagawa, Yutaka Wakasa, Shinji Kume, Hiroaki Satoh, Takehiro Kato, Toshinari Takamura, Masao Toyoda, Satoshi Miyamoto, Mari Kitada, Masaji Miyamoto, Yasushi Ômura, Hiroshi Arima, Shin‐ichi Araki, Takeshi Onoue, Akimichi Asano, Daisuke Yabe, Osamu Sekine, Kenichi Tanaka, Hideki Kamiya, Daisuke Suzuki, Hideki Nishimura, Yoshikata Morita, Tomohiko Ito, Motohide Isono
article en

Abstract

Although the primary endpoint did not reach statistical significance, luseogliflozin may provide renoprotective benefits in patients with type 2 diabetes mellitus and moderate-to-severe renal impairment, potentially by slowing eGFRcreat decline post-initial decline.

Journal of Diabetes InvestigationVol. 16(12)
Kanazawa University (JP), Tokai University (JP), Suzuki (Japan) (JP), Shiga University of Medical Science (JP), Aichi Medical University (JP), Kanazawa Medical University (JP), University of Occupational and Environmental Health Japan (JP), Wakayama Medical University (JP), Taoka Hospital (JP), Kanazawa Medical Center (JP), Fukuoka University Hospital (JP), Shiga University of Medical Science Hospital (JP), Okayama University Hospital (JP), Kawamura Hospital (JP), Ishikawa Prefectural Central Hospital (JP), Koga Hospital (JP), Kanazawa Medical University Hospital (JP), Keiju Medical Center (JP), Juntendo University Urayasu Hospital (JP), Nagahama City Hospital (JP), Shiga Medical Center (JP), Gifu University (JP), Nagoya University (JP)
Kanazawa University, Kanazawa Medical University
Openalex Percentile: Top 62%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.